Zealand Pharma obesity drug showed disappointing weight loss in a Phase 2 trial.
Disappointing weight-loss-drug trial results from Zealand Pharma send shares tumbling
Related Posts
Popular News
Latest News
Heading to Portugal? Banana Republic’s Summer Edit Is Filled With Packing List Essentials
When you think of popular Euro trip destinations, there are a few countries that often come to mind… France, Spain,...
Trump may say he’s banning Wall Street from buying homes. Does the bipartisan housing bill actually do that?
The measure “will take time to meaningfully affect housing affordability and will not resolve voter frustration in that area,” analysts...
Ethereum recruits top researchers as Joe Lubin backs Ethlabs
Ethereum has added a new independent research organization backed by Joe Lubin, Bitmine, and Sharplink, bringing together five former Ethereum...
Wall Street loves growth stocks — but these 10 ‘losers’ are primed to win
Elon Musk’s $1 trillion SpaceX prediction is probably wrong. Contrarian investors are buying these out-of-favor value plays instead.
Welcome to Global Finances Daily, your go-to source for all things finance. Our mission is to provide our readers with valuable information and insights to help them achieve their financial goals and secure their financial future.